{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:06:47Z","timestamp":1790291207488,"version":"4.1.0"},"reference-count":246,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The central nervous system (CNS) is immune-privileged by several immuno-modulators as interleukins (ILs). ILs are cytokines secreted by immune cells for cell-cell signaling communications and affect the functions of the CNS. ILs were reported to orchestrate different molecular and cellular mechanisms of both physiological and pathological events, through overproduction or over-expression of their receptors. They interact with numerous receptors mediating pro-inflammatory and\/or anti-inflammatory actions. Interleukins have been implicated to participate in neurodegenerative diseases. They play a critical role in Alzheimer\u2019s disease (AD) pathology which is characterized by the over-production of pro-inflammatory ILs. These may aggravate neurodegeneration, in addition to their contribution to detrimental mechanisms as oxidative stress, and excitotoxicity. However, recent research on the relation between ILs and AD revealed major discrepancies. Most of the major ILs were shown to play both pro- and anti-inflammatory roles in different experimental settings and models. The interactions between different ILs through shared pathways also add to the difficulty of drawing solid conclusions. In addition, targeting the different ILs has not yielded consistent results. The repeated failures of therapeutic drugs in treating AD necessitate the search for novel agents targeting multiple mechanisms of the disease pathology. In this context, the understanding of interleukins and their roles throughout the disease progression and interaction with other systems in the brain may provide promising therapeutic targets for the prevention or treatment of AD.<\/jats:p>","DOI":"10.1007\/s11011-025-01538-5","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T06:05:28Z","timestamp":1738389928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Brain interleukins and Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Heba G.","family":"Abdelhamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A.","family":"Sakraan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa T.","family":"Al-Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba S.","family":"Aboul Ezz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neveen A.","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser A.","family":"Khadrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasr M.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"1538_CR1","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1074\/jbc.M207577200","volume":"278","author":"S Aggarwal","year":"2003","unstructured":"Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910\u20131914","journal-title":"J Biol Chem"},{"key":"1538_CR2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.2174\/1381612822666160125114503","volume":"22","author":"T Ahmed","year":"2016","unstructured":"Ahmed T, Setzer N, Fazel Nabavi S, Erdogan Orhan I, Braidy N, Sobarzo-Sanchez E et al (2016) Insights into effects of ellagic acid on the nervous system: a mini review. Curr Pharmaceut Des 22:1350\u20131360","journal-title":"Curr Pharmaceut Des"},{"key":"1538_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1533317512467680","volume":"28","author":"MA Alsadany","year":"2013","unstructured":"Alsadany MA, Shehata HH, Mohamad MI, Mahfouz RG (2013) Histone deacetylases enzyme, copper, and IL-8 levels in patients with Alzheimer\u2019s disease. Am J Alzh Dis Other Demen 28:54\u201361","journal-title":"Am J Alzh Dis Other Demen"},{"key":"1538_CR4","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/brain\/awx109","volume":"140","author":"S Alves","year":"2017","unstructured":"Alves S, Churlaud G, Audrain M, Michaelsen-Preusse K, Fol R, Souchet B, Braudeau J et al (2017) Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer\u2019s disease mice. Brain 140:826\u2013842","journal-title":"Brain"},{"key":"1538_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41590-020-0776-4","volume":"21","author":"K Alves de Lima","year":"2020","unstructured":"Alves de Lima K, Rustenhoven J, Da Mesquita S, Wall M, Salvador AF et al (2020) Meningeal gd T cells regulate anxiety-like behavior via IL-17a signaling inneurons. Nat Immunol 21:1421\u20131429","journal-title":"Nat Immunol"},{"key":"1538_CR6","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s Association (2023) Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 19(4). https:\/\/doi.org\/10.1002\/alz.13016","DOI":"10.1002\/alz.13016"},{"key":"1538_CR7","first-page":"IJTR","volume":"3","author":"G Anderson","year":"2010","unstructured":"Anderson G, Ojala JO (2010) Alzheimer\u2019s and seizures: interleukin-18, indoleamine 2, 3-dioxygenase and quinolinic acid. Int J Trypt Res 3:IJTR\u2013S4603","journal-title":"Int J Trypt Res"},{"key":"1538_CR8","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.2337\/diacare.26.9.2622","volume":"26","author":"Y Aso","year":"2003","unstructured":"Aso Y, Okumura K, Takebayashi K, Wakabayashi S, Inukai T (2003) Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes. Diabet Care 26:2622\u20132627","journal-title":"Diabet Care"},{"key":"1538_CR9","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1523\/JNEUROSCI.21-09-03104.2001","volume":"21","author":"A Bachis","year":"2001","unstructured":"Bachis A, Colangelo AM, Vicini S, Doe PP, De Bernardi MA, Brooker G et al (2001) Interleukin-10 prevents glutamate-mediated cerebellar granule cell death by blocking caspase-3-like activity. J Neurosci 21:3104\u20133112","journal-title":"J Neurosci"},{"key":"1538_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jns.2017.03.031","volume":"376","author":"E Bagyinszky","year":"2017","unstructured":"Bagyinszky E, Van Giau V, Shim K, Suk K, An SSA, Kim S (2017) Role of inflammatory molecules in the Alzheimer\u2019s disease progression and diagnosis. J Neurol Sci 376:242\u2013254","journal-title":"J Neurol Sci"},{"key":"1538_CR11","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1096\/fj.04-1625fje","volume":"18","author":"D Balschun","year":"2004","unstructured":"Balschun D, Wetzel W, Del Rey A, Pitossi F, Schneider H, Zuschratter W et al (2004) Interleukin-6: a cytokine to forget. FASEB J 18:1788\u20131790","journal-title":"FASEB J"},{"key":"1538_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/342918a0","volume":"342","author":"B Barbour","year":"1989","unstructured":"Barbour B, Szatkowski M, Ingledew N, Attwell D (1989) Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 342:918\u2013920","journal-title":"Nature"},{"key":"1538_CR13","doi-asserted-by":"publisher","first-page":"14641","DOI":"10.1523\/JNEUROSCI.2173-12.2012","volume":"32","author":"RM Barrientos","year":"2012","unstructured":"Barrientos RM, Hein AM, Frank MG, Watkins LR, Maier SF (2012) Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats. J Neurosci 32:14641\u201314648","journal-title":"J Neurosci"},{"key":"1538_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.nbd.2018.10.009","volume":"121","author":"I Barroeta-Espar","year":"2019","unstructured":"Barroeta-Espar I, Weinstock LD, Perez-Nievas BG, Meltzer AC, Chong MST, Amaral AC et al (2019) Distinct cytokine profiles in human brains resilient to Alzheimer\u2019s pathology. Neurobiol Dis 121:327\u2013337","journal-title":"Neurobiol Dis"},{"key":"1538_CR15","doi-asserted-by":"crossref","unstructured":"Beck RD, King MA, Ha GK, Cushman JD, Huang Z et al (2005) IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins. J Neuroimmun 160:146\u2013153","DOI":"10.1016\/j.jneuroim.2004.11.006"},{"key":"1538_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000052830","volume":"48","author":"Y Beloosesky","year":"2002","unstructured":"Beloosesky Y, Salman H, Bergman M, Bessler H, Djaldetti M (2002) Cytokine levels and phagocytic activity in patients with Alzheimer\u2019s disease. Gerontology 48:128\u2013132","journal-title":"Gerontology"},{"key":"1538_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuint.2010.02.013","volume":"57","author":"S Ben Achour","year":"2010","unstructured":"Ben Achour S, Pascual O (2010) Glia: The many ways to modulate synaptic plasticity. Neurochem Int 57:440\u2013445","journal-title":"Neurochem Int"},{"key":"1538_CR18","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/sj.npp.1301612","volume":"33","author":"K Biber","year":"2008","unstructured":"Biber K, Pinto-Duarte A, Wittendorp MC, Dolga AM, Fernandes CC, K\u00fcnzel JVFD (2008) Interleukin-6 upregulates neuronal adenosine A 1 receptors: implications for neuromodulation and neuroprotection. Neuropsychopharmacology 33:2237\u20132250","journal-title":"Neuropsychopharmacology"},{"key":"1538_CR19","doi-asserted-by":"publisher","first-page":"e0117282","DOI":"10.1371\/journal.pone.0117282","volume":"10","author":"RJ Bishnoi","year":"2015","unstructured":"Bishnoi RJ, Palmer RF, Royall DR (2015) Serum interleukin (IL)-15 as a biomarker of Alzheimer\u2019s disease. PLoS ONE 10:e0117282","journal-title":"PLoS ONE"},{"key":"1538_CR20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"1538_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77\u201398","journal-title":"Prog Neurobiol"},{"key":"1538_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12011","volume":"39","author":"D Boche","year":"2013","unstructured":"Boche D, Perry VH, Nicoll JAR (2013) Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39:3\u201318","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1538_CR23","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jnnp.2006.103242","volume":"78","author":"P Boss\u00f9","year":"2007","unstructured":"Boss\u00f9 P, Ciaramella A, Moro ML, Bellincampi L, Bernardini S, Federici G et al (2007) Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer\u2019s disease. J Neurol Neurosurg Psychiat 78:807\u2013811","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"1538_CR24","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.2174\/138161210794519147","volume":"16","author":"P Boss\u00f9","year":"2010","unstructured":"Boss\u00f9 P, Ciaramella A, Salani F, Vanni D, Palladino I, Caltagirone C et al (2010) Interleukin-18, from neuroinflammation to Alzheimer\u2019s disease. Curr Pharmaceut Des 16:4213\u20134224","journal-title":"Curr Pharmaceut Des"},{"key":"1538_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/576383","volume":"2013","author":"A Boutajangout","year":"2013","unstructured":"Boutajangout A, Wisniewski T (2013) The innate immune system in Alzheimer\u2019s disease. Int J CellBiol 2013:1\u20137","journal-title":"Int J CellBiol"},{"key":"1538_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2362.2006.01657.x","volume":"36","author":"N Brabers","year":"2006","unstructured":"Brabers N, Nottet H (2006) Role of the pro-inflammatory cytokines TNF-\u03b1 and IL\u20101\u03b2 in HIV-associated dementia. Europ J Clin Invest 36:447\u2013458","journal-title":"Europ J Clin Invest"},{"key":"1538_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1053\/sarh.2001.23701","volume":"30","author":"B Bresnihan","year":"2001","unstructured":"Bresnihan B (2001) The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis. Seminars Arthrit Rheumat 30:17\u201320","journal-title":"Seminars Arthrit Rheumat"},{"key":"1538_CR28","doi-asserted-by":"publisher","first-page":"109574","DOI":"10.1016\/j.celrep.2021.109574","volume":"36","author":"HC Brigas","year":"2021","unstructured":"Brigas HC, Ribeiro M, Coelho JE, Gomes R, Gomez-Murcia V, Carvalho K et al (2021) IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer\u2019s disease. Cell Rep 36:109574","journal-title":"Cell Rep"},{"key":"1538_CR29","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT (2014) Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol 50:534\u2013544","journal-title":"Mol Neurobiol"},{"key":"1538_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.expneurol.2015.03.020","volume":"275","author":"JE Burda","year":"2016","unstructured":"Burda JE, Bernstein AM, Sofroniew MV (2016) Astrocyte roles in traumatic brain injury. Exp Neurol 275:305\u2013315","journal-title":"Exp Neurol"},{"key":"1538_CR31","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bbi.2011.10.008","volume":"26","author":"MD Burton","year":"2012","unstructured":"Burton MD, Johnson RW (2012) Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning. Brain Behav Immun 26:732\u2013738","journal-title":"Brain Behav Immun"},{"key":"1538_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1471-4159.2009.06397.x","volume":"111","author":"DA Butterfield","year":"2009","unstructured":"Butterfield DA, Lange MLB (2009) Multifunctional roles of enolase in Alzheimer\u2019s disease brain: beyond altered glucose metabolism. J Neurochem 111:915\u2013933","journal-title":"J Neurochem"},{"key":"1538_CR33","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE et al (2001) In-vivo measurement of activated microglia in dementia. Lancet 358:461\u2013467","journal-title":"Lancet"},{"key":"1538_CR34","doi-asserted-by":"publisher","unstructured":"Cao K, Liao X, Lu J, Yao S, Wu F, Zhu X, Shi D, Wen S, Liu L, Zhou H (2018) IL-33\/ST2 plays a critical role in endothelial cell activation and microglia-mediated neuroinflammation modulation. J Neuroinflammation 15(1):136. https:\/\/doi.org\/10.1186\/s12974-018-1169-6","DOI":"10.1186\/s12974-018-1169-6"},{"key":"1538_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12979-023-00397-x","volume":"20","author":"M Cao","year":"2023","unstructured":"Cao M, Liu J, Zhang X, Wang Y, Hou Y, Song Q, Cui Y, Zhao Y, Wang P (2023) IL-17A promotes the progression of Alzheimer\u2019s disease in APP\/PS1 mice. Immun Ageing 20:74","journal-title":"Immun Ageing"},{"key":"1538_CR36","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.18632\/oncotarget.6798","volume":"7","author":"M Capello","year":"2016","unstructured":"Capello M, Ferri-Borgogno S, Riganti C, Chattaragada MS, Principe M, Roux C et al (2016) Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. Oncotarget 7:5598","journal-title":"Oncotarget"},{"key":"1538_CR37","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1038\/tp.2017.142","volume":"7","author":"C Carlock","year":"2017","unstructured":"Carlock C, Wu J, Shim J, Moreno-Gonzalez I, Pitcher MR, Hicks J et al (2017) Interleukin 33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice. Translat Psychiat 7:e1164\u2013e1164","journal-title":"Translat Psychiat"},{"issue":"9","key":"1538_CR38","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.4049\/jimmunol.153.9.4258","volume":"153","author":"E Cash","year":"1994","unstructured":"Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O (1994) Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 153(9):4258\u20134267","journal-title":"J Immunol"},{"key":"1538_CR39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1096\/fj.09-141754","volume":"24","author":"P Chakrabarty","year":"2010","unstructured":"Chakrabarty P, Jansen-West K, Beccard A, Ceballos-Diaz C, Levites Y, Verbeeck C et al (2010) Massive gliosis induced by interleukin-6 suppresses A\u03b2 deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J 24:548\u2013559","journal-title":"FASEB J"},{"key":"1538_CR40","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/mp.2009.10","volume":"14","author":"J Chapuis","year":"2009","unstructured":"Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C et al (2009) Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer\u2019s disease. Mol Psychiat 14:1004\u20131016","journal-title":"Mol Psychiat"},{"key":"1538_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000360606","volume":"38","author":"JM Chen","year":"2014","unstructured":"Chen JM, Jiang GX, Li QW, Zhou ZM, Cheng Q (2014a) Increased serum levels of interleukin-18,-23 and-17 in Chinese patients with Alzheimer\u2019s disease. Dement Ger Cog Disord 38:321\u2013329","journal-title":"Dement Ger Cog Disord"},{"key":"1538_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2013.11.036","volume":"266","author":"X Chen","year":"2014","unstructured":"Chen X, Duan XS, Xu LJ, Zhao JJ, She ZF, Chen WW et al (2014b) Interleukin-10 mediates the neuroprotection of hyperbaric oxygen therapy against traumatic brain injury in mice. Neuroscience 266:235\u2013243","journal-title":"Neuroscience"},{"key":"1538_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature20818","volume":"542","author":"C Chen","year":"2017","unstructured":"Chen C, Itakura E, Nelson GM, Sheng M, Laurent P et al (2017) IL-17 is a neuromodulator of Caenorhabditis elegans sensory responses. Nature 542:43\u201348","journal-title":"Nature"},{"key":"1538_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0411-8","volume":"12","author":"JD Cherry","year":"2015","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK (2015) Arginase 1\u2009+\u2009microglia reduce A\u03b2 plaque deposition during IL-1\u03b2-dependent neuroinflammation. J Neuroinflamm 12:1\u201313","journal-title":"J Neuroinflamm"},{"key":"1538_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T (2020) Translating IL-6 biology into effective treatments. Nat Rev Rheumat 16:335\u2013345","journal-title":"Nat Rev Rheumat"},{"key":"1538_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.intimp.2014.12.035","volume":"24","author":"A Cianciulli","year":"2015","unstructured":"Cianciulli A, Dragone T, Calvello R, Porro C, Trotta T, Lofrumento DD et al (2015) IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int Immunopharmacol 24:369\u2013376","journal-title":"Int Immunopharmacol"},{"key":"1538_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4161\/mabs.1.3.8593","volume":"1","author":"O Cingoz","year":"2009","unstructured":"Cingoz O (2009) Ustekinumab. MAbs 1:216\u2013221","journal-title":"MAbs"},{"key":"1538_CR48","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q","volume":"28","author":"CJP Clarke","year":"1998","unstructured":"Clarke CJP, Hales A, Hunt A, Foxwell BMJ (1998) IL-10-mediated suppression of TNF-\u03b1 production is independent of its ability to inhibit NF\u03baB activity. Eur J Immunol 28:1719\u20131726","journal-title":"Eur J Immunol"},{"key":"1538_CR49","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1111\/bph.14586","volume":"176","author":"C Cristiano","year":"2019","unstructured":"Cristiano C, Volpicelli F, Lippiello P, Buono B, Raucci F, Piccolo M et al (2019) Neutralization of IL-17 rescues amyloid-\u03b2-induced neuroinflammation and memory impairment. Brit J Pharm 176:3544\u20133557","journal-title":"Brit J Pharm"},{"key":"1538_CR50","doi-asserted-by":"publisher","first-page":"e12050","DOI":"10.1002\/trc2.12050","volume":"6","author":"J Cummings","year":"2020","unstructured":"Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K (2020) Alzheimer\u2019s disease drug development pipeline: 2020. Alzheimers Dement (N Y) 6:e12050","journal-title":"Alzheimers Dement (N Y)"},{"key":"1538_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0306-4522(01)00405-5","volume":"108","author":"B Curran","year":"2001","unstructured":"Curran B, O\u2019Connor JJ (2001) The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108:83\u201390","journal-title":"Neuroscience"},{"key":"1538_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000328989","volume":"33","author":"M Czeh","year":"2011","unstructured":"Czeh M, Gressens P, Kaindl AM (2011) The Yin and Yang of microglia. Develop Neurosci 33:199\u2013209","journal-title":"Develop Neurosci"},{"key":"1538_CR53","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V et al (2016) Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 139:1237\u20131251","journal-title":"Brain"},{"key":"1538_CR54","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1126\/science.1090349","volume":"302","author":"ST DeKosky","year":"2003","unstructured":"DeKosky ST, Marek K (2003) Looking backward to move forward: early detection of neurodegenerative disorders. Science 302:830\u2013834","journal-title":"Science"},{"key":"1538_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-019-0524-x","volume":"11","author":"JL Del-Aguila","year":"2019","unstructured":"Del-Aguila JL, Li Z, Dube U et al (2019) A single-nuclei RNA sequencing study of mendelian and sporadic AD in the human brain. Alzheimers Res Ther 11:71","journal-title":"Alzheimers Res Ther"},{"key":"1538_CR56","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/jcbfm.2008.10","volume":"28","author":"Y Deng-Bryant","year":"2008","unstructured":"Deng-Bryant Y, Singh IN, Carrico KM, Hall ED (2008) Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite-derived free radicals, in a mouse traumatic brain injury model. J Cereb Blood Flow Metab 28:1114\u20131126","journal-title":"J Cereb Blood Flow Metab"},{"key":"1538_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresrev.2008.07.003","volume":"59","author":"D Di Bona","year":"2008","unstructured":"Di Bona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C et al (2008) Association between the interleukin-1\u03b2 polymorphisms and Alzheimer\u2019s disease: a systematic review and meta-analysis. Brain Res Rev 59:155\u2013163","journal-title":"Brain Res Rev"},{"key":"1538_CR58","doi-asserted-by":"publisher","first-page":"870","DOI":"10.2174\/1567205014666170317113606","volume":"14","author":"C Domingues","year":"2017","unstructured":"Domingues C, da Cruz e Silva OAB, Henriques AG (2017) Impact of cytokines and chemokines on Alzheimer\u2019s disease neuropathological hallmarks. Curr Alzheimer Res 14:870\u201382","journal-title":"Curr Alzheimer Res"},{"key":"1538_CR59","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/aps.2009.24","volume":"30","author":"X Dong","year":"2009","unstructured":"Dong X, Wang Y, Qin Z (2009) Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sinica 30:379\u2013387","journal-title":"Acta Pharmacol Sinica"},{"key":"1538_CR60","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/neu.2015.4373","volume":"34","author":"CR Dorsett","year":"2017","unstructured":"Dorsett CR, McGuire JL, DePasquale EAK, Gardner AE, Floyd CL, McCullumsmith RE (2017) Glutamate neurotransmission in rodent models of traumatic brain injury. J Neurotrauma 34:263\u2013272","journal-title":"J Neurotrauma"},{"key":"1538_CR61","doi-asserted-by":"publisher","first-page":"e48530","DOI":"10.15252\/embr.201948530","volume":"21","author":"P Eede","year":"2020","unstructured":"Eede P, Obst J, Benke E, Yvon-Durocher G, Richard BC, Gimber N et al (2020) Interleukin-12\/23 deficiency differentially affects pathology in male and female Alzheimer\u2019s disease-like mice. EMBO Rep 21:e48530","journal-title":"EMBO Rep"},{"key":"1538_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11010-016-2762-6","volume":"420","author":"HK Elcioglu","year":"2016","unstructured":"Elcioglu HK, Aslan E, Ahmad S, Alan S, Salva E et al (2016) Tocilizumab\u2019s effect on cognitive deficits induced by intracerebroventricular administration of streptozotocin in Alzheimer\u2019s model. Mol Cell Biochem 420:21\u201328","journal-title":"Mol Cell Biochem"},{"key":"1538_CR63","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1210\/jcem.87.8.8781","volume":"87","author":"K Esposito","year":"2002","unstructured":"Esposito K, Pontillo A, Ciotola M, Di Palo C, Grella E, Nicoletti G et al (2002) Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 87:3864\u20133866","journal-title":"J Clin Endocrinol Metab"},{"key":"1538_CR64","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12974-018-1205-6","volume":"15","author":"L Facci","year":"2018","unstructured":"Facci L, Barbierato M, Zusso M, Skaper SD, Giusti P (2018) Serum amyloid a primes microglia for ATP-dependent interleukin-1beta release. J Neuroinflamm 15:164","journal-title":"J Neuroinflamm"},{"key":"1538_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neulet.2007.01.052","volume":"416","author":"A Familian","year":"2007","unstructured":"Familian A, Eikelenboom P, Veerhuis R (2007) Minocycline does not affect amyloid \u03b2 phagocytosis by human microglial cells. Neurosci Lett 416:87\u201391","journal-title":"Neurosci Lett"},{"key":"1538_CR66","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/BF03401753","volume":"4","author":"M Fiala","year":"1998","unstructured":"Fiala M, Zhang L, Gan X et al (1998) Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med 4:480\u2013489","journal-title":"Mol Med"},{"key":"1538_CR67","doi-asserted-by":"publisher","first-page":"610813","DOI":"10.1155\/2015\/610813","volume":"2015","author":"R Fischer","year":"2015","unstructured":"Fischer R, Maier O (2015) Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev 2015:610813","journal-title":"Oxid Med Cell Longev"},{"key":"1538_CR68","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2967\/jnumed.118.217703","volume":"60","author":"C Focke","year":"2019","unstructured":"Focke C, Blume T, Zott B et al (2019) Early and longitudinal microglial activation but not amyloid accumulation predicts cognitive outcome in PS2APP mice. J Nucl Med 60:548\u2013554","journal-title":"J Nucl Med"},{"key":"1538_CR69","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuroscience.2008.10.021","volume":"158","author":"JP Forder","year":"2009","unstructured":"Forder JP, Tymianski M (2009) Postsynaptic mechanisms of excitotoxicity: involvement of postsynaptic density proteins, radicals, and oxidant molecules. Neuroscience 158:293\u2013300","journal-title":"Neuroscience"},{"key":"1538_CR70","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1159\/000255051","volume":"28","author":"OV Forlenza","year":"2009","unstructured":"Forlenza OV, Diniz BS, Talib LL, Mendon\u00e7a VA, Ojopi EB, Gattaz WF et al (2009) Increased serum IL-1\u03b2 level in Alzheimer\u2019s disease and mild cognitive impairment. Dement Ger Cogn Disord 28:507\u2013512","journal-title":"Dement Ger Cogn Disord"},{"key":"1538_CR71","doi-asserted-by":"publisher","unstructured":"Frayling TM, Rafiq S, Murray A, Hurst AJ, Weedon MN, Henley W, Bandinelli S, Corsi AM, Ferrucci L, Guralnik JM, Wallace RB, Melzer D (2007) Aninterleukin-18 polymorphism is associated with reduced serum concentrations and better physical functioning in older people. J Gerontol A Biol Sci Med Sci 62(1):73\u201378. https:\/\/doi.org\/10.1093\/gerona\/62.1.73","DOI":"10.1093\/gerona\/62.1.73"},{"key":"1538_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuron.2017.11.028","volume":"97","author":"S Frere","year":"2018","unstructured":"Frere S, Slutsky I (2018) Alzheimer\u2019s disease: from firing instability to homeostasis network collapse. Neuron 97:32\u201358","journal-title":"Neuron"},{"key":"1538_CR73","doi-asserted-by":"publisher","first-page":"E2705","DOI":"10.1073\/pnas.1604032113","volume":"113","author":"AKY Fu","year":"2016","unstructured":"Fu AKY, Hung KW, Yuen MYF, Zhou X, Mak DSY, Chan ICW et al (2016) IL-33 ameliorates Alzheimer\u2019s disease-like pathology and cognitive decline. Proceed Nat Acad Sci 113:E2705\u2013E2713","journal-title":"Proceed Nat Acad Sci"},{"key":"1538_CR74","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.4049\/jimmunol.1202246","volume":"189","author":"SP Gadani","year":"2012","unstructured":"Gadani SP, Cronk JC, Norris GT, Kipnis J et al (2012) IL-4 in the brain: a cytokine to remember. J Immunol 189:4213\u20134219","journal-title":"J Immunol"},{"key":"1538_CR75","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1001\/archneur.63.4.538","volume":"63","author":"D Galimberti","year":"2006","unstructured":"Galimberti D, Schoonenboom N, Scheltens P, Fenoglio C, Bouwman F, Venturelli E, Guidi I, Blankenstein MA, Bresolin N, Scarpini E et al (2006) Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease. Arch Neurol 63:538\u2013543","journal-title":"Arch Neurol"},{"key":"1538_CR76","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/01.jcp.0000125683.74595.2f","volume":"24","author":"F Gambi","year":"2004","unstructured":"Gambi F, Reale M, Iarlori C, Salone A, Toma L, Paladini C et al (2004) Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1\u03b2 levels and expression in peripheral blood mononuclear cells. J Clin Psychopharmacol 24:314\u2013321","journal-title":"J Clin Psychopharmacol"},{"key":"1538_CR77","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fpsyt.2010.00136","volume":"1","author":"CJ Garwood","year":"2010","unstructured":"Garwood CJ, Cooper JD, Hanger DP, Noble W (2010) Anti-inflammatory impact of minocycline in a mouse model of tauopathy. Front Psychiat 1:136","journal-title":"Front Psychiat"},{"key":"1538_CR78","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","volume":"33","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA et al (2013) Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci 33:5053\u20135064","journal-title":"J Neurosci"},{"key":"1538_CR79","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/glia.20628","volume":"56","author":"D G\u00f3mez-Nicola","year":"2008","unstructured":"G\u00f3mez-Nicola D, Valle-Argos B, Pita-Thomas DW, Nieto-Sampedro M (2008) Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury. Glia 56:494\u2013505. https:\/\/doi.org\/10.1002\/glia.20628","journal-title":"Glia"},{"key":"1538_CR80","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.amjms.2016.04.012","volume":"352","author":"Y Gonul","year":"2016","unstructured":"Gonul Y, Kazand\u0131 S, Kocak A, Ahsen A, Bal A, Karavelioglu A et al (2016) Interleukin-18 binding protein pretreatment attenuates kidney injury induced by hepatic ischemia reperfusion. Am J Med Sci 352:200\u2013207","journal-title":"Am J Med Sci"},{"key":"1538_CR81","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s11306-015-0773-z","volume":"11","author":"R Gonzalez-Dominguez","year":"2015","unstructured":"Gonzalez-Dominguez R, Garcia-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomic research on the role of interleukin-4 in Alzheimer\u2019s disease. Metabolomics 11:1175\u20131183","journal-title":"Metabolomics"},{"key":"1538_CR82","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.06.010","volume":"103","author":"A Griciuc","year":"2019","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK et al (2019) TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease. Neuron 103:820\u2013835","journal-title":"Neuron"},{"issue":"6","key":"1538_CR83","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000107700","volume":"4","author":"RJ Guerreiro","year":"2007","unstructured":"Guerreiro RJ, Santana I, Br\u00e1s JM, Santiago B, Paiva A, Oliveira C (2007) Peripheral inflammatory cytokines as biomarkers in Alzheimer\u2019s disease and mild cognitive impairment. Neurodegener Dis 4(6):406\u2013412. https:\/\/doi.org\/10.1159\/000107700","journal-title":"Neurodegener Dis"},{"issue":"3","key":"1538_CR84","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.neuron.2014.12.068","volume":"85","author":"MV Guillot-Sestier","year":"2015","unstructured":"Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J Jr, Leung BP, Rezai-Zadeh K et al (2015) Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85(3):534\u2013548. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.068","journal-title":"Neuron"},{"issue":"2","key":"1538_CR85","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3233\/JAD-2012-111481","volume":"31","author":"JR Hall","year":"2012","unstructured":"Hall JR, Johnson LA, Barber RC, Vo HT, Winter AS, O\u2019Bryant SE (2012) Biomarkers of basic activities of daily living in Alzheimer\u2019s disease. J Alzheimers Dis 31(2):429\u2013437. https:\/\/doi.org\/10.3233\/JAD-2012-111481","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1538_CR86","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/JAD-122359","volume":"35","author":"JR Hall","year":"2013","unstructured":"Hall JR, Wiechmann AR, Johnson LA, Edwards M, Barber RC, Winter AS et al (2013) Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer\u2019s disease. J Alzheimers Dis 35(2):363\u2013371. https:\/\/doi.org\/10.3233\/JAD-122359","journal-title":"J Alzheimers Dis"},{"key":"1538_CR87","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/aww017","volume":"139","author":"L Hamelin","year":"2016","unstructured":"Hamelin L, Lagarde J, Dorothee G et al (2016) Clinical IMABio3 team. Early and protective microglial activation in Alzheimer\u2019s disease: a prospective study using 18F-DPA-714 PET imaging. Brain 139:1252\u20131264","journal-title":"Brain"},{"issue":"2","key":"1538_CR88","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1271\/bbb.67.396","volume":"67","author":"F Hashimoto","year":"2003","unstructured":"Hashimoto F, Ono M, Masuoka C, Ito Y, Sakata Y, Shimizu K et al (2003) Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols. Biosci Biotechnol Biochem 67(2):396\u2013401. https:\/\/doi.org\/10.1271\/bbb.67.396","journal-title":"Biosci Biotechnol Biochem"},{"key":"1538_CR89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jsbmb.2013.05.010","volume":"142","author":"VW Henderson","year":"2014","unstructured":"Henderson VW (2014) Alzheimer\u2019s disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol 142:99\u2013106. https:\/\/doi.org\/10.1016\/j.jsbmb.2013.05.010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"13","key":"1538_CR90","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1073\/pnas.0909586107","volume":"107","author":"MT Heneka","year":"2010","unstructured":"Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D et al (2010) Locus ceruleus controls Alzheimer\u2019s disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci U S A 107(13):6058\u20136063. https:\/\/doi.org\/10.1073\/pnas.0909586107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"1538_CR91","doi-asserted-by":"publisher","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","volume":"28","author":"SE Hickman","year":"2008","unstructured":"Hickman SE, Allison EK, El Khoury J (2008) Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer\u2019s disease mice. J Neurosci 28(33):8354\u20138360. https:\/\/doi.org\/10.1523\/JNEUROSCI.0616-08.2008","journal-title":"J Neurosci"},{"issue":"6","key":"1538_CR92","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00401-010-0667-0","volume":"119","author":"WT Hu","year":"2010","unstructured":"Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM et al (2010) Novel CSF biomarkers for Alzheimer\u2019s disease and mild cognitive impairment. Acta Neuropathol 119(6):669\u2013678. https:\/\/doi.org\/10.1007\/s00401-010-0667-0","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1538_CR93","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","volume":"79","author":"WT Hu","year":"2012","unstructured":"Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE et al (2012) Alzheimer\u2019s disease neuroimaging initiative. Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79(9):897\u2013905. https:\/\/doi.org\/10.1212\/WNL.0b013e318266fa70","journal-title":"Neurology"},{"issue":"6","key":"1538_CR94","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/BF00571510","volume":"89","author":"M Huell","year":"1995","unstructured":"Huell M, Strauss S, Volk B, Berger M, Bauer J (1995) Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer\u2019s disease patients. Acta Neuropathol 89(6):544\u2013551. https:\/\/doi.org\/10.1007\/BF00571510","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1538_CR95","doi-asserted-by":"publisher","first-page":"e36893","DOI":"10.1371\/journal.pone.0036893","volume":"7","author":"JM Hunter","year":"2012","unstructured":"Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C et al (2012) Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer\u2019s disease. PLoS ONE 7(5):e36893. https:\/\/doi.org\/10.1371\/journal.pone.0036893","journal-title":"PLoS ONE"},{"key":"1538_CR96","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12974-018-1376-1","volume":"15","author":"P Italiani","year":"2018","unstructured":"Italiani P, Puxeddu I, Napoletano S, Scala E, Melillo D et al (2018) Circulating levels of IL-1 family cytokines and receptors in Alzheimer\u2019s disease: new markers of disease progression? J Neuroinflamm 15:342","journal-title":"J Neuroinflamm"},{"issue":"10 Suppl 4","key":"1538_CR97","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1212\/wnl.66.10_suppl_4.s24","volume":"66","author":"P Jenner","year":"2006","unstructured":"Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson\u2019s disease. Neurology 66(10 Suppl 4):S24\u201336. https:\/\/doi.org\/10.1212\/wnl.66.10_suppl_4.s24","journal-title":"Neurology"},{"key":"1538_CR98","doi-asserted-by":"publisher","first-page":"634020","DOI":"10.3389\/fncel.2021.634020","volume":"15","author":"SJB Jesudasan","year":"2021","unstructured":"Jesudasan SJB, Gupta SJ, Churchward MA, Todd KG, Winship IR (2021) Inflammatory cytokine profile and plasticity of brain and spinal microglia in response to ATP and glutamate. Front Cell Neurosci 15:634020","journal-title":"Front Cell Neurosci"},{"key":"1538_CR99","doi-asserted-by":"publisher","unstructured":"Jin W, Dong C (2013) IL-17 cytokines in immunity and inflammation. Emerg Microbes Infect 2(9):e60. https:\/\/doi.org\/10.1038\/emi.2013.58","DOI":"10.1038\/emi.2013.58"},{"issue":"1","key":"1538_CR100","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1046\/j.1432-1327.2001.01867.x","volume":"268","author":"T Jostock","year":"2001","unstructured":"Jostock T, M\u00fcllberg J, Ozbek S, Atreya R, Blinn G, Voltz N et al (2001) Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem 268(1):160\u2013167. https:\/\/doi.org\/10.1046\/j.1432-1327.2001.01867.x","journal-title":"Eur J Biochem"},{"issue":"1","key":"1538_CR101","doi-asserted-by":"publisher","first-page":"e01504","DOI":"10.1002\/brb3.1504","volume":"10","author":"H Katayama","year":"2020","unstructured":"Katayama H (2020) Anti-interleukin-17A and anti-interleukin-23 antibodies may be effective against Alzheimer\u2019s disease: role of neutrophils in the pathogenesis. Brain Behav 10(1):e01504. https:\/\/doi.org\/10.1002\/brb3.1504","journal-title":"Brain Behav"},{"key":"1538_CR102","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuroscience.2012.01.049","volume":"207","author":"K Kawahara","year":"2012","unstructured":"Kawahara K, Suenobu M, Yoshida A, Koga K, Hyodo A, Ohtsuka H et al (2012) Intracerebral microinjection of interleukin-4\/interleukin-13 reduces \u03b2-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Neuroscience 207:243\u2013260. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.01.049","journal-title":"Neuroscience"},{"key":"1538_CR103","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/exd.12487","volume":"23","author":"RR Keijsers","year":"2014","unstructured":"Keijsers RR, Joosten I, van Erp PE, Koenen HJPM, van de Kerkhof PCM (2014) Cellular sources of IL-17 in psoriasis: a paradigm shift? Exp Dermatol 23:799\u2013803. https:\/\/doi.org\/10.1111\/exd.12487","journal-title":"Exp Dermatol"},{"issue":"5","key":"1538_CR104","doi-asserted-by":"publisher","first-page":"e95318","DOI":"10.1371\/journal.pone.0095318","volume":"9","author":"VL Keleshian","year":"2014","unstructured":"Keleshian VL, Kellom M, Kim HW, Taha AY, Cheon Y, Igarashi M et al (2014) Neuropathological responses to chronic NMDA in rats are worsened by dietary n-3 PUFA deprivation but are not ameliorated by fish oil supplementation. PLoS ONE 9(5):e95318. https:\/\/doi.org\/10.1371\/journal.pone.0095318","journal-title":"PLoS ONE"},{"issue":"49","key":"1538_CR105","doi-asserted-by":"publisher","first-page":"45564","DOI":"10.1074\/jbc.M108757200","volume":"276","author":"A Kelly","year":"2001","unstructured":"Kelly A, Lynch A, Vereker E, Nolan Y, Queenan P, Whittaker E et al (2001) The anti-inflammatory cytokine, interleukin (IL)-10, blocks the inhibitory effect of IL-1 beta on long term potentiation. A role for JNK. J Biol Chem 276(49):45564\u201345572. https:\/\/doi.org\/10.1074\/jbc.M108757200","journal-title":"J Biol Chem"},{"issue":"9","key":"1538_CR106","doi-asserted-by":"publisher","first-page":"e44260","DOI":"10.1371\/journal.pone.0044260","volume":"7","author":"SJ Kiddle","year":"2012","unstructured":"Kiddle SJ, Thambisetty M, Simmons A, Riddoch-Contreras J, Hye A, Westman E et al (2012) Plasma based markers of [11\u00a0C] PiB-PET brain amyloid burden. PLoS ONE 7(9):e44260. https:\/\/doi.org\/10.1371\/journal.pone.0044260","journal-title":"PLoS ONE"},{"issue":"12","key":"1538_CR107","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","volume":"187","author":"M Kitazawa","year":"2011","unstructured":"Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD, Vasilevko V et al (2011) Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model. J Immunol 187(12):6539\u20136549. https:\/\/doi.org\/10.4049\/jimmunol.1100620","journal-title":"J Immunol"},{"issue":"8","key":"1538_CR108","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1096\/fj.10-155317","volume":"24","author":"T Kiyota","year":"2010","unstructured":"Kiyota T, Okuyama S, Swan RJ, Jacobsen MT, Gendelman HE, Ikezu T (2010) CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer\u2019s disease-like pathogenesis in APP\u2009+\u2009PS1 bigenic mice. FASEB J 24(8):3093\u20133102. https:\/\/doi.org\/10.1096\/fj.10-155317","journal-title":"FASEB J"},{"issue":"7","key":"1538_CR109","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/gt.2011.126","volume":"19","author":"T Kiyota","year":"2012","unstructured":"Kiyota T, Ingraham KL, Swan RJ, Jacobsen MT, Andrews SJ, Ikezu T (2012) AAV serotype 2\/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP\u2009+\u2009PS1 mice. Gene Ther 19(7):724\u2013733. https:\/\/doi.org\/10.1038\/gt.2011.126","journal-title":"Gene Ther"},{"key":"1538_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20060043","volume":"112","author":"JP Konsman","year":"2007","unstructured":"Konsman JP, Drukarch B, Van Dam AM (2007) (Peri) vascular production and action of pro-inflammatory cytokines in brain pathology. Clin Sci 112:1\u201325","journal-title":"Clin Sci"},{"key":"1538_CR111","doi-asserted-by":"crossref","unstructured":"Koriauli S, Barbakadze T, Natsvlishvili N, Dabrundashvili N, Kvaratskhelia E, Mikeladze D (2014) IL-10 Gene knockout reduces the expression of mGlu receptor 1a\/b and decreases the glutamate-dependent production of nitric oxide. J Biomed Sci Eng 7(13):1019\u20131029","DOI":"10.4236\/jbise.2014.713099"},{"issue":"1","key":"1538_CR112","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","volume":"28","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi M, Dixit VM (2012) Inflammasomes and their roles in health and disease. Ann Rev Cell Develop Biol 28(1):137\u2013161","journal-title":"Ann Rev Cell Develop Biol"},{"issue":"1\u20132","key":"1538_CR113","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0165-5728(03)00031-6","volume":"136","author":"A Ledeboer","year":"2003","unstructured":"Ledeboer A, Wierinckx A, Bol JGJM, Floris S, de Lavalette CR, De Vries HE et al (2003) Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE. J Neuroimmunol 136(1\u20132):94\u2013103","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1538_CR114","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jnr.10253","volume":"69","author":"YB Lee","year":"2002","unstructured":"Lee YB, Nagai A, Kim SU (2002) Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69(1):94\u2013103","journal-title":"J Neurosci Res"},{"key":"1538_CR115","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1742-2094-7-56","volume":"7","author":"DC Lee","year":"2010","unstructured":"Lee DC, Rizer J, Selenica ML et al (2010) LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J Neuroinflammation 7:56","journal-title":"J Neuroinflammation"},{"key":"1538_CR116","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17:157\u2013172","journal-title":"Nat Rev Neurol"},{"key":"1538_CR117","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3164\/jcbn.22-105","volume":"73","author":"P Li","year":"2023","unstructured":"Li P, He Y, Yang Q et al (2023) NEK7 inhibition attenuates A\u03b2-induced cognitive impairment by regulating TLR4\/NF-\u03baB and the NLRP3 inflammasome in mice. J Clin Biochem Nutr 73:22\u2013105","journal-title":"J Clin Biochem Nutr"},{"issue":"2","key":"1538_CR118","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neurobiolaging.2012.05.017","volume":"34","author":"L Liu","year":"2013","unstructured":"Liu L, Martin R, Chan C (2013) Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases. Neurobiol Aging 34(2):540\u2013550","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"1538_CR119","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jneuroim.2014.03.013","volume":"271","author":"Y Liu","year":"2014","unstructured":"Liu Y, Yu JT, Zhang W, Zong Y, Lu RC, Zhou J et al (2014) Interleukin-23 receptor polymorphisms are associated with Alzheimer\u2019s disease in Han Chinese. J Neuroimmunol 271(1\u20132):43\u201348. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.03.013","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1538_CR120","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339","journal-title":"Cell"},{"key":"1538_CR121","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/alz.12341","volume":"17","author":"AB Lopez-Rodriguez","year":"2021","unstructured":"Lopez-Rodriguez AB, Hennessy E, Murray CL, Nazmi A, Delaney HJ et al (2021) Acute systemic inflammation exacerbates neuroinflammation in Alzheimer\u2019s disease: IL-1beta drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimers Dement 17:1735\u20131755","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1538_CR122","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1515\/hsz-2013-0241","volume":"395","author":"J Lugrin","year":"2014","unstructured":"Lugrin J, Rosenblatt-Velin N, Parapanov R, Liaudet L (2014) The role of oxidative stress during inflammatory processes. Biol Chem 395(2):203\u2013230. https:\/\/doi.org\/10.1515\/hsz-2013-0241","journal-title":"Biol Chem"},{"issue":"3","key":"1538_CR123","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1471-4159.2006.04370.x","volume":"101","author":"A Lyons","year":"2007","unstructured":"Lyons A, Griffin RJ, Costelloe CE, Clarke RM, Lynch MA (2007) IL-4 attenuates the neuroinflammation induced by amyloid-beta in vivo and in vitro. J Neurochem 101(3):771\u2013781. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04370.x","journal-title":"J Neurochem"},{"issue":"1","key":"1538_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01349-z","volume":"11","author":"NM Lyra e Silva","year":"2021","unstructured":"Lyra e Silva NM, Gon\u00e7alves RA, Pascoal TA, Lima-Filho RAS, Resende EPF, Vieira ELM et al (2021) Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer\u2019s disease. Transl Psychiat 11(1):1\u201315","journal-title":"Transl Psychiat"},{"issue":"3","key":"1538_CR125","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1179\/016164107X158974","volume":"29","author":"BE Mace","year":"2007","unstructured":"Mace BE, Wang H, Lynch JR, Moss J, Sullivan P, Colton H, Morgan K, Renauld JC, Laskowitz DT (2007) Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway. Neurol Res 29(3):243\u2013250. https:\/\/doi.org\/10.1179\/016164107X158974","journal-title":"Neurol Res"},{"key":"1538_CR126","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1590\/0004-282X20170110","volume":"75","author":"CA Magalh\u00e3es","year":"2017","unstructured":"Magalh\u00e3es CA, Carvalho MDG, De Sousa LP, Caramelli P, Gomes KB (2017) Alzheimer\u2019s disease and cytokine IL-10 gene polymorphisms: is there an association? Arq Neuropsiquiatr 75:649\u2013656. https:\/\/doi.org\/10.1590\/0004-282X20170110","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"1538_CR127","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11481-008-9133-3","volume":"4","author":"KA Maguire-Zeiss","year":"2009","unstructured":"Maguire-Zeiss KA, Federoff HJ (2009) Immune-directed gene therapeutic development for Alzheimer\u2019s, prion, and Parkinson\u2019s diseases. J Neuroimmune Pharmacol 4(3):298\u2013308. https:\/\/doi.org\/10.1007\/s11481-008-9133-3","journal-title":"J Neuroimmune Pharmacol"},{"issue":"5","key":"1538_CR128","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.neurobiolaging.2004.07.002","volume":"26","author":"FO Maher","year":"2005","unstructured":"Maher FO, Nolan Y, Lynch MA (2005) Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol Aging 26(5):717\u2013728. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2004.07.002","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1538_CR129","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/GME.0000000000000681","volume":"23","author":"PM Maki","year":"2016","unstructured":"Maki PM, Henderson VW (2016) Cognition and the menopause transition. Menopause 23(7):803\u20135. https:\/\/doi.org\/10.1097\/GME.0000000000000681","journal-title":"Menopause"},{"issue":"14","key":"1538_CR130","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/hc3901.096721","volume":"104","author":"Z Mallat","year":"2001","unstructured":"Mallat Z, Corbaz A, Scoazec A, Besnard S, Les\u00e8che G, Chvatchko Y (2001) Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 104(14):1598\u20131603. https:\/\/doi.org\/10.1161\/hc3901.096721","journal-title":"Circulation"},{"issue":"6012","key":"1538_CR131","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330(6012):1774. https:\/\/doi.org\/10.1126\/science.1197623Epub 2010 Dec 9. PMID: 21148344; PMCID: PMC3073454","journal-title":"Science"},{"issue":"7869","key":"1538_CR132","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","volume":"595","author":"CS McAlpine","year":"2021","unstructured":"McAlpine CS, Park J, Griciuc A, Kim E, Choi SH, Iwamoto Y et al (2021) Astrocytic interleukin-3 programs microglia and limits Alzheimer\u2019s disease. Nature 595(7869):701\u2013706. https:\/\/doi.org\/10.1038\/s41586-021-03734-6","journal-title":"Nature"},{"issue":"2","key":"1538_CR133","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/jcbfm.2009.217","volume":"30","author":"BW McColl","year":"2010","unstructured":"McColl BW, Rose N, Robson FH, Rothwell NJ, Lawrence CB (2010) Increased brain microvascular MMP-9 and incidence of haemorrhagic transformation in obese mice after experimental stroke. J Cereb Blood Flow Metab 30(2):267\u2013272. https:\/\/doi.org\/10.1038\/jcbfm.2009.217","journal-title":"J Cereb Blood Flow Metab"},{"key":"1538_CR134","doi-asserted-by":"publisher","first-page":"1196413","DOI":"10.3389\/fphar.2023.1196413","volume":"14","author":"D Melchiorri","year":"2023","unstructured":"Melchiorri D, Merlo S, Micallef B, Borg JJ, Drafi F (2023) Alzheimer\u2019s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy? Front Pharmacol 14:1196413","journal-title":"Front Pharmacol"},{"issue":"7","key":"1538_CR135","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1161\/ATVBAHA.119.311994","volume":"39","author":"JE Mindur","year":"2019","unstructured":"Mindur JE, Swirski FK (2019) Growth factors as immunotherapeutic targets in cardiovascular disease. Arterioscler Thromb Vasc Biol 39(7):1275\u20131287. https:\/\/doi.org\/10.1161\/ATVBAHA.119.311994","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"1538_CR136","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1080\/08820139.2018.1504300","volume":"47","author":"V Mohammadi Shahrokhi","year":"2018","unstructured":"Mohammadi Shahrokhi V, Ravari A, Mirzaei T, Zare-Bidaki M, Asadikaram G, Arababadi MK (2018) IL-17A and IL-23: plausible risk factors to induce age-associated inflammation in Alzheimer\u2019s disease. Immunol Invest 47(8):812\u2013822. https:\/\/doi.org\/10.1080\/08820139.2018.1504300","journal-title":"Immunol Invest"},{"key":"1538_CR137","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fncel.2014.00112","volume":"8","author":"I Morales","year":"2014","unstructured":"Morales I, Guzm\u00e1n-Mart\u00ednez L, Cerda-Troncoso C, Far\u00edas GA, Maccioni RB (2014) Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8:112. https:\/\/doi.org\/10.3389\/fncel.2014.00112","journal-title":"Front Cell Neurosci"},{"key":"1538_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mgene.2016.01.001","volume":"8","author":"MJ Mun","year":"2016","unstructured":"Mun MJ, Kim JH, Choi JY, Jang WC (2016) Genetic polymorphisms of interleukin genes and the risk of Alzheimer\u2019s disease: an update meta-analysis. Meta Gene 8:1\u201310. https:\/\/doi.org\/10.1016\/j.mgene.2016.01.001","journal-title":"Meta Gene"},{"issue":"12","key":"1538_CR139","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.neurobiolaging.2012.02.015","volume":"33","author":"PS Murray","year":"2012","unstructured":"Murray PS, Kirkwood CM, Gray MC, Ikonomovic MD, Paljug WR, Abrahamson EE et al (2012) \u03b2-Amyloid 42\/40 ratio and kalirin expression in Alzheimer disease with psychosis. Neurobiol Aging 33(12):2807\u20132816. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.02.015","journal-title":"Neurobiol Aging"},{"issue":"1","key":"1538_CR140","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1002\/cpns.81","volume":"89","author":"A Myers","year":"2019","unstructured":"Myers A, McGonigle P (2019) Overview of transgenic mouse models for Alzheimer\u2019s disease. Curr Protoc Neurosci 89(1):e81. https:\/\/doi.org\/10.1002\/cpns.81","journal-title":"Curr Protoc Neurosci"},{"issue":"2\u20133","key":"1538_CR141","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000111535","volume":"56","author":"KS Na","year":"2007","unstructured":"Na KS, Kim YK (2007) Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophrenia. Neuropsychobiology 56(2\u20133):55\u201363. https:\/\/doi.org\/10.1159\/000111535","journal-title":"Neuropsychobiology"},{"issue":"12","key":"1538_CR142","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1089\/ars.2011.4175","volume":"16","author":"JH Nam","year":"2012","unstructured":"Nam JH, Park KW, Park ES, Lee YB, Lee HG, Baik HH, Kim YS, Maeng S, Park J, Jin BK (2012) Interleukin-13\/-4-induced oxidative stress contributes to death of hippocampal neurons in a\u03b21-42-treated hippocampus in vivo. Antioxid Redox Signal 16(12):1369\u20131383. https:\/\/doi.org\/10.1089\/ars.2011.4175","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"1538_CR143","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1196\/annals.1427.002","volume":"1147","author":"DG Nicholls","year":"2008","unstructured":"Nicholls DG (2008) Oxidative stress and energy crises in neuronal dysfunction. Ann NY Acad Sci 1147(1):53\u201360","journal-title":"Ann NY Acad Sci"},{"key":"1538_CR144","doi-asserted-by":"publisher","unstructured":"Nishimoto N, Kishimoto T (2008) Humanized antihuman IL-6 receptor antibody, tocilizumab. Handb Exp Pharmacol 181151\u2013160. https:\/\/doi.org\/10.1007\/978-3-540-73259-4_7","DOI":"10.1007\/978-3-540-73259-4_7"},{"key":"1538_CR145","doi-asserted-by":"publisher","first-page":"639353","DOI":"10.3389\/fneur.2021.639353","volume":"12","author":"L Nitsch","year":"2021","unstructured":"Nitsch L, Schneider L, Zimmermann J, M\u00fcller M (2021) Microglia-derived interleukin 23: a crucial cytokine in Alzheimer\u2019s disease? Front Neurol 12:639353. https:\/\/doi.org\/10.3389\/fneur.2021.639353","journal-title":"Front Neurol"},{"key":"1538_CR146","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3389\/fimmu.2018.01213","volume":"9","author":"TJ Oberstein","year":"2018","unstructured":"Oberstein TJ, Taha L, Spitzer P, Hellstern J, Herrmann M, Kornhuber J, Maler JM (2018) Imbalance of circulating Th17 and regulatory T cells in Alzheimer\u2019s disease: a case control study. Front Immunol 9:1213. https:\/\/doi.org\/10.3389\/fimmu.2018.01213","journal-title":"Front Immunol"},{"issue":"5","key":"1538_CR147","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/jcm6050055","volume":"6","author":"JO Ojala","year":"2017","unstructured":"Ojala JO, Sutinen EM (2017) The role of Interleukin-18, oxidative stress and metabolic syndrome in Alzheimer\u2019s Disease. J Clin Med 6(5):55. https:\/\/doi.org\/10.3390\/jcm6050055","journal-title":"J Clin Med"},{"issue":"1\u20132","key":"1538_CR148","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jneuroim.2008.09.012","volume":"205","author":"JO Ojala","year":"2008","unstructured":"Ojala JO, Sutinen EM, Salminen A, Pirttil\u00e4 T (2008) Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol 205(1\u20132):86\u201393. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.09.012","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1538_CR149","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neurobiolaging.2007.06.006","volume":"30","author":"J Ojala","year":"2009","unstructured":"Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttil\u00e4 T (2009) Expression of interleukin-18 is increased in the brains of Alzheimer\u2019s disease patients. Neurobiol Aging 30(2):198\u2013209. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.06.006","journal-title":"Neurobiol Aging"},{"issue":"43","key":"1538_CR150","doi-asserted-by":"publisher","first-page":"40302","DOI":"10.1074\/jbc.M206428200","volume":"277","author":"C Opazo","year":"2002","unstructured":"Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, White AR et al (2002) Metalloenzyme-like activity of Alzheimer\u2019s disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 277(43):40302\u201340308. https:\/\/doi.org\/10.1074\/jbc.M206428200","journal-title":"J Biol Chem"},{"key":"1538_CR151","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","volume":"72","author":"T Ozben","year":"2019","unstructured":"Ozben T, Ozben S (2019) Neuro-inflammation and anti-inflammatory treatment options for Alzheimer\u2019s disease. Clin Biochem 72:87\u201389","journal-title":"Clin Biochem"},{"key":"1538_CR152","doi-asserted-by":"crossref","unstructured":"Paquet C, Boche D, El Bouchtaoui M, Gourmaud S, Janin A, Bousquet G (2017) Effect of anti-cancer drugs on microglia in patient-derived breast cancer xenografted mouse models. Neuropathology 37(1):1\u20133","DOI":"10.1111\/neup.12323"},{"issue":"12","key":"1538_CR153","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.1038\/cddis.2013.503","volume":"4","author":"B Parajuli","year":"2013","unstructured":"Parajuli B, Sonobe Y, Horiuchi H, Takeuchi H, Mizuno T, Suzumura A (2013) Oligomeric amyloid \u03b2 induces IL-1\u03b2 processing via production of ROS: implication in Alzheimer\u2019s disease. Cell Death Dis 4(12):e975. https:\/\/doi.org\/10.1038\/cddis.2013.503","journal-title":"Cell Death Dis"},{"issue":"6","key":"1538_CR154","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/emm.2007.88","volume":"39","author":"KW Park","year":"2007","unstructured":"Park KW, Lee HG, Jin BK, Lee YB (2007) Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo. Exp Mol Med 39(6):812\u2013819. https:\/\/doi.org\/10.1038\/emm.2007.88","journal-title":"Exp Mol Med"},{"issue":"7","key":"1538_CR155","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.4049\/jimmunol.0803392","volume":"183","author":"KW Park","year":"2009","unstructured":"Park KW, Baik HH, Jin BK (2009) IL-13-induced oxidative stress via microglial NADPH oxidase contributes to death of hippocampal neurons in vivo. J Immunol 183(7):4666\u20134674. https:\/\/doi.org\/10.4049\/jimmunol.0803392","journal-title":"J Immunol"},{"key":"1538_CR156","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5483\/BMBREP.2020.53.1.309","volume":"53","author":"JC Park","year":"2020","unstructured":"Park JC, Han SH, Mook-Jung I (2020) Peripheral inflammatory biomarkers in Alzheimer\u2019s disease: a brief review. BMB Rep 53:10\u201319. https:\/\/doi.org\/10.5483\/BMBREP.2020.53.1.309","journal-title":"BMB Rep"},{"issue":"1","key":"1538_CR157","doi-asserted-by":"publisher","first-page":"14057","DOI":"10.1038\/s41598-017-14020-9","volume":"7","author":"S Pedrini","year":"2017","unstructured":"Pedrini S, Gupta VB, Hone E, Doecke J, O\u2019Bryant S, James I et al (2017) A blood-based biomarker panel indicates IL-10 and IL-12\/23p40 are jointly associated as predictors of \u03b2-amyloid load in an AD cohort. Sci Rep 7(1):14057. https:\/\/doi.org\/10.1038\/s41598-017-14020-9","journal-title":"Sci Rep"},{"issue":"4","key":"1538_CR158","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","volume":"6","author":"VH Perry","year":"2010","unstructured":"Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6(4):193\u2013201. https:\/\/doi.org\/10.1038\/nrneurol.2010.17","journal-title":"Nat Rev Neurol"},{"issue":"24","key":"1538_CR159","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.2174\/0929867323666160809100452","volume":"23","author":"T Persichini","year":"2016","unstructured":"Persichini T, Mariotto S, Suzuki H, Butturini E, Mastrantonio R, Cantoni O et al (2016) Cross-talk between NO synthase isoforms in neuro-inflammation: possible implications in HIV-associated neurocognitive disorders. Curr Med Chem 23(24):2706\u20132714","journal-title":"Curr Med Chem"},{"key":"1538_CR160","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0079-6123(07)63020-9","volume":"163","author":"M Pickering","year":"2007","unstructured":"Pickering M, O\u2019Connor JJ (2007) Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res 163:339\u2013354. https:\/\/doi.org\/10.1016\/S0079-6123(07)63020-9","journal-title":"Prog Brain Res"},{"key":"1538_CR161","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/cells13010054","volume":"13","author":"D Plantone","year":"2024","unstructured":"Plantone D, Pardini M, Righi D et al (2024) The role of TNF-\u03b1 in Alzheimer\u2019s disease: a narrative review. Cells 13:54","journal-title":"Cells"},{"key":"1538_CR162","doi-asserted-by":"publisher","first-page":"1263771","DOI":"10.3389\/fnins.2023.1263771","volume":"17","author":"A Pless","year":"2023","unstructured":"Pless A, Ware D, Saggu S et al (2023) Understanding neuropsychiatric symptoms in Alzheimer\u2019s disease: challenges and advances in diagnosis and treatment. Front Neurosci 17:1263771","journal-title":"Front Neurosci"},{"issue":"3","key":"1538_CR163","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archneur.60.3.369","volume":"60","author":"PN Pompl","year":"2003","unstructured":"Pompl PN, Yemul S, Xiang Z, Ho L, Haroutunian V, Purohit D, Mohs R, Pasinetti GM (2003) Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease. Arch Neurol 60(3):369\u2013376. https:\/\/doi.org\/10.1001\/archneur.60.3.369","journal-title":"Arch Neurol"},{"issue":"1\u20132","key":"1538_CR164","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0165-5728(03)00158-9","volume":"139","author":"Z Qiu","year":"2003","unstructured":"Qiu Z, Gruol DL (2003) Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons. J Neuroimmunol 139(1\u20132):51\u201357. https:\/\/doi.org\/10.1016\/s0165-5728(03)00158-9","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1538_CR165","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","volume":"295","author":"RA Quintanilla","year":"2004","unstructured":"Quintanilla RA, Orellana DI, Gonz\u00e1lez-Billault C, Maccioni RB (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway. Exp Cell Res 295(1):245\u201357. https:\/\/doi.org\/10.1016\/j.yexcr.2004.01.002","journal-title":"Exp Cell Res"},{"key":"1538_CR166","doi-asserted-by":"publisher","first-page":"100149","DOI":"10.1016\/j.crphar.2022.100149","volume":"4","author":"V Rani","year":"2023","unstructured":"Rani V, Verma R, Kumar K et al (2023) Role of pro-inflammatory cytokines in Alzheimer\u2019s disease and neuroprotective effects of pegylated self-assembled nanoscaffolds. Curr Res Pharmacol Drug Discov 4:100149","journal-title":"Curr Res Pharmacol Drug Discov"},{"issue":"1\u20132","key":"1538_CR167","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jneuroim.2003.11.003","volume":"148","author":"M Reale","year":"2004","unstructured":"Reale M, Iarlori C, Gambi F, Feliciani C, Salone A, Toma L et al (2004) Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J Neuroimmunol 148(1\u20132):162\u2013171. https:\/\/doi.org\/10.1016\/j.jneuroim.2003.11.003","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1538_CR168","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/jad-2008-14203","volume":"14","author":"M Reale","year":"2008","unstructured":"Reale M, Iarlori C, Feliciani C, Gambi D (2008) Peripheral chemokine receptors, their ligands, cytokines and Alzheimer\u2019s disease. J Alzheimers Dis 14(2):147\u2013159. https:\/\/doi.org\/10.3233\/jad-2008-14203","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"1538_CR169","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2174\/138955709789055199","volume":"9","author":"M Reale","year":"2009","unstructured":"Reale M, Greig NH, Kamal MA (2009) Peripheral chemo-cytokine profiles in Alzheimer\u2019s and Parkinson\u2019s diseases. Mini Rev Med Chem 9(10):1229\u20131241. https:\/\/doi.org\/10.2174\/138955709789055199","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"1538_CR170","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz C, Brayne C, Mayeux R (2011) Epidemiology of Alzheimer disease. Nat Rev Neurol 7(3):137\u2013152","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1538_CR171","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0891988706286226","volume":"19","author":"M Rentzos","year":"2006","unstructured":"Rentzos M, Zoga M, Paraskevas GP, Kapaki E, Rombos A, Nikolaou C et al (2006) IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer\u2019s disease and frontotemporal dementia. J Geriatr Psychiatry Neurol 19(2):114\u2013117. https:\/\/doi.org\/10.1177\/0891988706286226","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"1538_CR172","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1176\/jnp.2007.19.3.318","volume":"19","author":"M Rentzos","year":"2007","unstructured":"Rentzos M, Paraskevas GP, Kapaki E, Nikolaou C, Zoga M, Tsoutsou A et al (2007) Circulating interleukin-15 in dementia disorders. J Neuropsychiatry Clin Neurosci 19(3):318\u2013325. https:\/\/doi.org\/10.1176\/jnp.2007.19.3.318","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"5 Pt 1","key":"1538_CR173","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1523\/JNEUROSCI.15-05-03318.1995","volume":"15","author":"IJ Reynolds","year":"1995","unstructured":"Reynolds IJ, Hastings TG (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci 15(5 Pt 1):3318\u20133327. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-05-03318.1995","journal-title":"J Neurosci"},{"issue":"40","key":"1538_CR174","doi-asserted-by":"publisher","first-page":"eaay5199","DOI":"10.1126\/sciimmunol.aay5199","volume":"4","author":"M Ribeiro","year":"2019","unstructured":"Ribeiro M, Brigas HC, Temido-Ferreira M, Pousinha PA, Regen T, Santa C et al (2019) Meningeal \u03b3\u03b4 T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci Immunol 4(40):eaay5199. https:\/\/doi.org\/10.1126\/sciimmunol.aay5199","journal-title":"Sci Immunol"},{"issue":"3","key":"1538_CR175","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10072-010-0221-9","volume":"31","author":"G Ribizzi","year":"2010","unstructured":"Ribizzi G, Fiordoro S, Barocci S, Ferrari E, Megna M (2010) Cytokine polymorphisms and Alzheimer disease: possible associations. Neurol Sci 31(3):321\u2013325. https:\/\/doi.org\/10.1007\/s10072-010-0221-9","journal-title":"Neurol Sci"},{"issue":"1","key":"1538_CR176","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0169-328x(97)00356-2","volume":"55","author":"GE Ringheim","year":"1998","unstructured":"Ringheim GE, Szczepanik AM, Petko W, Burgher KL, Zhu SZ, Chao CC (1998) Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor\/interleukin-6 complex. Brain Res Mol Brain Res 55(1):35\u201344. https:\/\/doi.org\/10.1016\/s0169-328x(97)00356-2","journal-title":"Brain Res Mol Brain Res"},{"key":"1538_CR177","doi-asserted-by":"publisher","unstructured":"Roh JS, Sohn DH (2018) Damage-associated molecular patterns in inflammatory diseases. Immune Netw 18. https:\/\/doi.org\/10.4110\/IN.2018.18.E27","DOI":"10.4110\/IN.2018.18.E27"},{"issue":"5","key":"1538_CR178","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3945\/jn.112.169516","volume":"143","author":"L Rojanathammanee","year":"2013","unstructured":"Rojanathammanee L, Puig KL, Combs CK (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr 143(5):597\u2013605. https:\/\/doi.org\/10.3945\/jn.112.169516","journal-title":"J Nutr"},{"issue":"2","key":"1538_CR179","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1034\/j.1600-079x.2003.00057.x","volume":"35","author":"S Rosales-Corral","year":"2003","unstructured":"Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Vel\u00e1zquez M, Mart\u00ednez-Barboza G, Acosta-Mart\u00ednez JP et al (2003) Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res 35(2):80\u201384. https:\/\/doi.org\/10.1034\/j.1600-079x.2003.00057.x","journal-title":"J Pineal Res"},{"issue":"1","key":"1538_CR180","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.22512","volume":"71","author":"S Rossi","year":"2012","unstructured":"Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F et al (2012) Interleukin-1\u03b2 causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol 71(1):76\u201383. https:\/\/doi.org\/10.1002\/ana.22512","journal-title":"Ann Neurol"},{"key":"1538_CR181","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1750-1326-9-56","volume":"9","author":"S Rossi","year":"2014","unstructured":"Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F et al (2014) Interleukin-1\u03b2 causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol Neurodegener 9:56. https:\/\/doi.org\/10.1186\/1750-1326-9-56","journal-title":"Mol Neurodegener"},{"key":"1538_CR182","doi-asserted-by":"publisher","first-page":"756357","DOI":"10.1100\/2012\/756357","volume":"2012","author":"JM Rubio-Perez","year":"2012","unstructured":"Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines. ScientificWorld J 2012:756357. https:\/\/doi.org\/10.1100\/2012\/756357","journal-title":"ScientificWorld J"},{"issue":"1","key":"1538_CR183","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1080\/13880209.2017.1319867","volume":"55","author":"N Sanadgol","year":"2017","unstructured":"Sanadgol N, Golab F, Tashakkor Z, Taki N, Moradi Kouchi S, Mostafaie A et al (2017) Neuroprotective effects of ellagic acid on cuprizone-induced acute demyelination through limitation of microgliosis, adjustment of CXCL12\/IL-17\/IL-11 axis and restriction of mature oligodendrocytes apoptosis. Pharm Biol 55(1):1679\u20131687. https:\/\/doi.org\/10.1080\/13880209.2017.1319867","journal-title":"Pharm Biol"},{"issue":"2","key":"1538_CR184","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3233\/JAD-131160","volume":"38","author":"M Saresella","year":"2014","unstructured":"Saresella M, Marventano I, Calabrese E, Piancone F, Rainone V, Gatti A et al (2014) A complex proinflammatory role for peripheral monocytes in Alzheimer\u2019s disease. J Alzheimers Dis 38(2):403\u2013413. https:\/\/doi.org\/10.3233\/JAD-131160","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1538_CR185","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-020-01806-4","volume":"17","author":"M Saresella","year":"2020","unstructured":"Saresella M, Marventano I, Piancone F, La Rosa F, Galimberti D, Fenoglio C et al (2020) IL-33 and its decoy sST2 in patients with Alzheimer\u2019s disease and mild cognitive impairment. J Neuroinflammation 17(1):174","journal-title":"J Neuroinflammation"},{"issue":"2\u20133","key":"1538_CR186","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","volume":"24","author":"M Sastre","year":"2006","unstructured":"Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer\u2019s disease: molecular mechanisms. Int J Dev Neurosci 24(2\u20133):167\u2013176. https:\/\/doi.org\/10.1016\/j.ijdevneu.2005.11.014","journal-title":"Int J Dev Neurosci"},{"key":"1538_CR187","doi-asserted-by":"publisher","unstructured":"Schneeberger S, Kim SJ, Eede P, Boltengagen A, Braeuning C et al (2021) The neuroinflammatory interleukin-12 signaling pathway drives Alzheimer\u2019s disease-like pathology by perturbing oligodendrocyte survival and neuronal homeostasis. bioRxiv preprint doi: https:\/\/doi.org\/10.1101\/2021.04.25.441313","DOI":"10.1101\/2021.04.25.441313"},{"issue":"6","key":"1538_CR188","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1172\/JCI31450","volume":"117","author":"SS Shaftel","year":"2007","unstructured":"Shaftel SS, Kyrkanides S, Olschowka JA, Miller JN, Johnson RE, O\u2019Banion MK (2007) Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 117(6):1595\u20131604. https:\/\/doi.org\/10.1172\/JCI31450","journal-title":"J Clin Invest"},{"issue":"3","key":"1538_CR189","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.arcmed.2006.10.007","volume":"38","author":"Y Shen","year":"2007","unstructured":"Shen Y, Zhang G, Liu L, Xu S (2007) Suppressive effects of melatonin on amyloid-beta-induced glial activation in rat hippocampus. Arch Med Res 38(3):284\u2013290. https:\/\/doi.org\/10.1016\/j.arcmed.2006.10.007","journal-title":"Arch Med Res"},{"issue":"9","key":"1538_CR190","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.4049\/jimmunol.181.9.6503","volume":"181","author":"E Shimizu","year":"2008","unstructured":"Shimizu E, Kawahara K, Kajizono M, Sawada M, Nakayama H (2008) IL-4-induced selective clearance of oligomeric beta-amyloid peptide(1\u201342) by rat primary type 2 microglia. J Immunol 181(9):6503\u20136513. https:\/\/doi.org\/10.4049\/jimmunol.181.9.6503","journal-title":"J Immunol"},{"issue":"3","key":"1538_CR191","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.immuni.2010.08.018","volume":"33","author":"V Siffrin","year":"2010","unstructured":"Siffrin V, Radbruch H, Glumm R, Niesner R, Paterka M, Herz J et al (2010) In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33(3):424\u2013436. https:\/\/doi.org\/10.1016\/j.immuni.2010.08.018","journal-title":"Immunity"},{"issue":"Pt 5","key":"1538_CR192","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1042\/BST0351122","volume":"35","author":"A Simi","year":"2007","unstructured":"Simi A, Tsakiri N, Wang P, Rothwell NJ (2007) Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 35(Pt 5):1122\u20131126. https:\/\/doi.org\/10.1042\/BST0351122","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"1538_CR193","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","volume":"26","author":"C Singer","year":"2003","unstructured":"Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M (2003) Alzheimer\u2019s disease cooperative study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer\u2019s disease. Sleep 26(7):893\u2013901. https:\/\/doi.org\/10.1093\/sleep\/26.7.893","journal-title":"Sleep"},{"issue":"10","key":"1538_CR194","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","volume":"69","author":"HD Soares","year":"2012","unstructured":"Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM et al (2012) Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch Neurol 69(10):1310\u20131317. https:\/\/doi.org\/10.1001\/archneurol.2012.1070","journal-title":"Arch Neurol"},{"issue":"10","key":"1538_CR195","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.1007\/s12035-016-0297-1","volume":"54","author":"M Sochocka","year":"2017","unstructured":"Sochocka M, Diniz BS, Leszek J (2017) Inflammatory response in the CNS: friend or foe? Mol Neurobiol 54(10):8071\u20138089. https:\/\/doi.org\/10.1007\/s12035-016-0297-1","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1538_CR196","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1750-3639.2008.00188.x","volume":"19","author":"A Sokolova","year":"2009","unstructured":"Sokolova A, Hill MD, Rahimi F, Warden LA, Halliday GM, Shepherd CE (2009) Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer\u2019s disease. Brain Pathol 19(3):392\u2013398. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00188.x","journal-title":"Brain Pathol"},{"key":"1538_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-6-1","volume":"6","author":"CM Sondag","year":"2009","unstructured":"Sondag CM, Dhawan G, Combs CK (2009) Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia. J Neuroinflammation 6:1. https:\/\/doi.org\/10.1186\/1742-2094-6-1","journal-title":"J Neuroinflammation"},{"issue":"5","key":"1538_CR198","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1046\/j.1471-4159.2001.00121.x","volume":"76","author":"DK Song","year":"2001","unstructured":"Song DK, Im YB, Jung JS, Cho J, Suh HW, Kim YH (2001) Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice. J Neurochem 76(5):1326\u20131335. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00121.x","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"1538_CR199","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.brainresrev.2011.01.002","volume":"67","author":"A Spooren","year":"2011","unstructured":"Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G et al (2011) Interleukin-6, a mental cytokine. Brain Res Rev 67(1\u20132):157\u2013183. https:\/\/doi.org\/10.1016\/j.brainresrev.2011.01.002","journal-title":"Brain Res Rev"},{"issue":"4","key":"1538_CR200","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s12640-009-9121-2","volume":"17","author":"C Spuch","year":"2010","unstructured":"Spuch C, Antequera D, Isabel Fernandez-Bachiller M, Isabel Rodr\u00edguez-Franco M, Carro E (2010) A new tacrine-melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer\u2019s disease. Neurotox Res 17(4):421\u2013431. https:\/\/doi.org\/10.1007\/s12640-009-9121-2","journal-title":"Neurotox Res"},{"issue":"1","key":"1538_CR201","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12035-016-0341-1","volume":"55","author":"L Stertz","year":"2018","unstructured":"Stertz L, Contreras-Shannon V, Monroy-Jaramillo N, Sun J, Walss-Bass C (2018) BACE1-Deficient mice exhibit alterations in immune system pathways. Mol Neurobiol 55(1):709\u2013717. https:\/\/doi.org\/10.1007\/s12035-016-0341-1","journal-title":"Mol Neurobiol"},{"key":"1538_CR202","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/jnc.15262","volume":"158","author":"N Stolero","year":"2020","unstructured":"Stolero N, Frenkel D (2020) The dialog between neurons and microglia in Alzheimer\u2019s disease: the neurotransmitters view. J Neurochem 158:1412\u20131424","journal-title":"J Neurochem"},{"issue":"5","key":"1538_CR203","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s12264-016-0055-4","volume":"32","author":"F Su","year":"2016","unstructured":"Su F, Bai F, Zhang Z (2016) Inflammatory cytokines and Alzheimer\u2019s disease: a review from the perspective of genetic polymorphisms. Neurosci Bull 32(5):469\u2013480. https:\/\/doi.org\/10.1007\/s12264-016-0055-4","journal-title":"Neurosci Bull"},{"issue":"1\u20132","key":"1538_CR204","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.brainres.2004.04.068","volume":"1015","author":"CS Sung","year":"2004","unstructured":"Sung CS, Wen ZH, Chang WK, Ho ST, Tsai SK, Chang YC et al (2004) Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res 1015(1\u20132):145\u2013153. https:\/\/doi.org\/10.1016\/j.brainres.2004.04.068","journal-title":"Brain Res"},{"key":"1538_CR205","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/1742-2094-9-199","volume":"9","author":"EM Sutinen","year":"2012","unstructured":"Sutinen EM, Pirttil\u00e4 T, Anderson G, Salminen A, Ojala JO (2012) Pro-inflammatory interleukin-18 increases Alzheimer\u2019s disease-associated amyloid-\u03b2 production in human neuron-like cells. J Neuroinflammation 9:199. https:\/\/doi.org\/10.1186\/1742-2094-9-199","journal-title":"J Neuroinflammation"},{"key":"1538_CR206","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fncel.2014.00214","volume":"8","author":"EM Sutinen","year":"2014","unstructured":"Sutinen EM, Korolainen MA, H\u00e4yrinen J, Alafuzoff I, Petratos S, Salminen A et al (2014) Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells. Front Cell Neurosci 8:214. https:\/\/doi.org\/10.3389\/fncel.2014.00214","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1538_CR207","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/s0165-5728(00)00404-5","volume":"113","author":"AM Szczepanik","year":"2001","unstructured":"Szczepanik AM, Funes S, Petko W, Ringheim GE (2001) IL-4, IL-10 and IL-13 modulate a beta(1\u201342)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113(1):49\u201362. https:\/\/doi.org\/10.1016\/s0165-5728(00)00404-5","journal-title":"J Neuroimmunol"},{"issue":"5","key":"1538_CR208","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/j.1471-4159.2007.05127.x","volume":"104","author":"Y Tachida","year":"2008","unstructured":"Tachida Y, Nakagawa K, Saito T, Saido TC, Honda T, Saito Y et al (2008) Interleukin-1\u03b2 up-regulates TACE to enhance \u03b1-cleavage of APP in neurons: resulting decrease in A\u03b2 production. J Neurochem 104(5):1387\u20131393","journal-title":"J Neurochem"},{"issue":"3","key":"1538_CR209","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/nan.12445","volume":"44","author":"R Taipa","year":"2018","unstructured":"Taipa R, Ferreira V, Brochado P, Robinson A, Reis I, Marques F et al (2018) Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem study. Neuropathol Appl Neurobiol 44(3):298\u2013313. https:\/\/doi.org\/10.1111\/nan.12445","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"1538_CR210","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ana.10519","volume":"53","author":"JL Takahashi","year":"2003","unstructured":"Takahashi JL, Giuliani F, Power C, Imai Y, Yong VW (2003) Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol 53(5):588\u2013595. https:\/\/doi.org\/10.1002\/ana.10519","journal-title":"Ann Neurol"},{"issue":"1","key":"1538_CR211","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.expneurol.2008.08.001","volume":"214","author":"H Takeuchi","year":"2008","unstructured":"Takeuchi H, Jin S, Suzuki H, Doi Y, Liang J, Kawanokuchi J et al (2008) Blockade of microglial glutamate release protects against ischemic brain injury. Exp Neurol 214(1):144\u2013146. https:\/\/doi.org\/10.1016\/j.expneurol.2008.08.001","journal-title":"Exp Neurol"},{"issue":"9","key":"1538_CR212","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.4103\/1673-5374.255975","volume":"14","author":"RH Tang","year":"2019","unstructured":"Tang RH, Qi RQ, Liu HY (2019) Interleukin-4 affects microglial autophagic flux. Neural Regen Res 14(9):1594\u20131602. https:\/\/doi.org\/10.4103\/1673-5374.255975","journal-title":"Neural Regen Res"},{"issue":"1","key":"1538_CR213","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1471-4159.2006.03872.x","volume":"98","author":"P Thornton","year":"2006","unstructured":"Thornton P, Pinteaux E, Gibson RM, Allan SM, Rothwell NJ (2006) Interleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical release. J Neurochem 98(1):258\u2013266. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03872.x","journal-title":"J Neurochem"},{"issue":"11","key":"1538_CR214","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1073\/pnas.93.11.5635","volume":"93","author":"CM Troy","year":"1996","unstructured":"Troy CM, Stefanis L, Prochiantz A, Greene LA, Shelanski ML (1996) The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper\/zinc superoxide dismutase down-regulation. Proc Natl Acad Sci U S A 93(11):5635\u20135640. https:\/\/doi.org\/10.1073\/pnas.93.11.5635","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1538_CR215","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.neulet.2012.03.084","volume":"516","author":"MV Turovskaya","year":"2012","unstructured":"Turovskaya MV, Turovsky EA, Zinchenko VP, Levin SG, Godukhin OV (2012) Interleukin-10 modulates [Ca2+] i response induced by repeated NMDA receptor activation with brief hypoxia through inhibition of InsP3-sensitive internal stores in hippocampal neurons. Neurosci Lett 516(1):151\u2013155","journal-title":"Neurosci Lett"},{"key":"1538_CR216","unstructured":"Upadhya S (2020) Neuron-specific cellular functions of Interleukin-9 in Alzheimer\u2019s disease. Emory Theses and Dissertations. https:\/\/etd.library.emory.edu\/concern\/etds\/2f75r9290?locale=en"},{"issue":"1","key":"1538_CR217","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0304-3940(94)90106-6","volume":"174","author":"E V\u00e1zquez","year":"1994","unstructured":"V\u00e1zquez E, Herrero I, Miras-Portugal MT, S\u00e1nchez-Prieto J (1994) Role of arachidonic acid in the facilitation of glutamate release from rat cerebrocortical synaptosomes independent of metabotropic glutamate receptor responses. Neurosci Lett 174(1):9\u201313","journal-title":"Neurosci Lett"},{"key":"1538_CR218","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.nbd.2019.04.010","volume":"127","author":"E Vico Varela","year":"2019","unstructured":"Vico Varela E, Etter G, Williams S (2019) Excitatory-inhibitory imbalance in Alzheimer\u2019s disease and therapeutic significance. Neurobiol Dis 127:605\u2013615","journal-title":"Neurobiol Dis"},{"issue":"25","key":"1538_CR219","doi-asserted-by":"publisher","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","volume":"23","author":"B Viviani","year":"2003","unstructured":"Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T et al (2003) Interleukin-1\u03b2 enhances NMDA receptor-mediated intracellular calcium increase through activation of the src family of kinases. J Neurosci 23(25):8692\u20138700","journal-title":"J Neurosci"},{"issue":"12","key":"1538_CR220","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/nm.2965","volume":"18","author":"J Vom Berg","year":"2012","unstructured":"Vom Berg J, Prokop S, Miller KR, Obst J, K\u00e4lin RE, Lopategui-Cabezas I et al (2012) Inhibition of IL-12\/IL-23 signaling reduces Alzheimer\u2019s disease\u2013like pathology and cognitive decline. Nat Med 18(12):1812\u20131819","journal-title":"Nat Med"},{"key":"1538_CR221","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1089\/ars.2011.4082","volume":"16","author":"R Von Bernhardi","year":"2012","unstructured":"Von Bernhardi R, Eugen\u00edn J (2012) Alzheimer\u2019s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid Redox Signal 16:974\u20131031","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"1538_CR222","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/j.1471-4159.2009.06537.x","volume":"112","author":"R von Bernhardi","year":"2010","unstructured":"von Bernhardi R, Tichauer JE, Eugen\u00edn J (2010) Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem 112(5):1099\u20131114","journal-title":"J Neurochem"},{"issue":"1","key":"1538_CR223","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2008.12.007","volume":"34","author":"V Vukic","year":"2009","unstructured":"Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO (2009) Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer\u2019s brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis 34(1):95\u2013106. https:\/\/doi.org\/10.1016\/j.nbd.2008.12.007","journal-title":"Neurobiol Dis"},{"issue":"6","key":"1538_CR224","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0197-4580(01)00306-2","volume":"22","author":"DG Walker","year":"2001","unstructured":"Walker DG, Lue LF, Beach TG (2001) Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging 22(6):957\u2013966","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1538_CR225","doi-asserted-by":"publisher","first-page":"e110024","DOI":"10.1371\/journal.pone.0110024","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang Y, Jin S, Sonobe Y, Cheng Y, Horiuchi H, Parajuli B et al (2014) Interleukin-1\u03b2 induces blood\u2013brain barrier disruption by downregulating sonic hedgehog in astrocytes. PLoS ONE 9(10):e110024","journal-title":"PLoS ONE"},{"key":"1538_CR226","unstructured":"Wang WY, Tan MS, Yu JT, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Annals Transl Med 3(10):136"},{"key":"1538_CR227","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbr.2015.09.003","volume":"296","author":"SW Wang","year":"2016","unstructured":"Wang SW, Yang SG, Liu W, Zhang YX, Xu PX, Wang T et al (2016) Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer\u2019s disease. Behav Brain Res 296:109\u2013117. https:\/\/doi.org\/10.1016\/j.bbr.2015.09.003","journal-title":"Behav Brain Res"},{"issue":"4","key":"1538_CR228","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/09168451.2018.1562874","volume":"83","author":"X Wang","year":"2019","unstructured":"Wang X, Zhang M, Liu H (2019) LncRNA17A regulates autophagy and apoptosis of SH-SY5Y cell line as an in vitro model for Alzheimer\u2019s disease. Biosci Biotech Biochem 83(4):609\u2013621","journal-title":"Biosci Biotech Biochem"},{"issue":"1","key":"1538_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-021-02211-1","volume":"18","author":"LL Weston","year":"2021","unstructured":"Weston LL, Jiang S, Chisholm D, Jantzie LL, Bhaskar K (2021) Interleukin-10 deficiency exacerbates inflammation-induced tau pathology. J Neuroinflamm 18(1):1\u201313","journal-title":"J Neuroinflamm"},{"issue":"43","key":"1538_CR230","doi-asserted-by":"publisher","first-page":"15511","DOI":"10.1523\/JNEUROSCI.3688-11.2011","volume":"31","author":"LL Williamson","year":"2011","unstructured":"Williamson LL, Sholar PW, Mistry RS, Smith SH, Bilbo SD (2011) Microglia and memory: modulation by early-life infection. J Neurosci 31(43):15511\u201315521","journal-title":"J Neurosci"},{"issue":"1","key":"1538_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep16622","volume":"5","author":"LB Wood","year":"2015","unstructured":"Wood LB, Winslow AR, Proctor EA, McGuone D, Mordes DA, Frosch MP et al (2015) Identification of neurotoxic cytokines by profiling Alzheimer\u2019s disease tissues and neuron culture viability screening. Sci Rep 5(1):1\u201313","journal-title":"Sci Rep"},{"issue":"5","key":"1538_CR232","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.3892\/mmr.2015.3183","volume":"11","author":"L Xie","year":"2015","unstructured":"Xie L, Lai Y, Lei F, Liu S, Liu R, Wang T (2015) Exploring the association between interleukin-1\u03b2 and its interacting proteins in Alzheimer\u2019s disease. Mol Med Rep 11(5):3219\u20133228","journal-title":"Mol Med Rep"},{"key":"1538_CR233","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-132081","volume":"2","author":"Z Xiong","year":"2014","unstructured":"Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A (2014) Alzheimer\u2019s disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimer\u2019s Disease 2:297\u2013308","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"8","key":"1538_CR234","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/0269881110367723","volume":"25","author":"X Yang","year":"2011","unstructured":"Yang X, Yang Y, Fu Z, Li Y, Feng J, Luo J (2011) Melatonin ameliorates Alzheimer-like pathological changes and spatial memory retention impairment induced by calyculin A. J Psychopharmacol 25(8):1118\u20131125","journal-title":"J Psychopharmacol"},{"key":"1538_CR235","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbi.2017.05.012","volume":"65","author":"J Yang","year":"2017","unstructured":"Yang J, Kou J, Lalonde R, Fukuchi K, Intracranial (2017) IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer\u2019s disease. Brain Behav Immun 65:262\u2013273","journal-title":"Brain Behav Immun"},{"issue":"3","key":"1538_CR236","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.pneurobio.2009.07.009","volume":"89","author":"JT Yu","year":"2009","unstructured":"Yu JT, Chang RCC, Tan L (2009) Calcium dysregulation in Alzheimer\u2019s disease: from mechanisms to therapeutic opportunities. Prog Neurobiol 89(3):240\u2013255","journal-title":"Prog Neurobiol"},{"issue":"1","key":"1538_CR237","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2202-8-82","volume":"8","author":"A Zambrano","year":"2007","unstructured":"Zambrano A, Otth C, Mujica L, Concha II, Maccioni RB (2007) Interleukin-3 prevents neuronal death induced by amyloid peptide. BMC Neurosci 8(1):1\u201311","journal-title":"BMC Neurosci"},{"issue":"7","key":"1538_CR238","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2174\/156720510793499011","volume":"7","author":"A Zambrano","year":"2010","unstructured":"Zambrano A, Otth C, Maccioni R, Concha I (2010) IL-3 control TAU modifications and protects cortical neurons from neurodegeneration. Curr Alzh Res 7(7):615\u2013624","journal-title":"Curr Alzh Res"},{"issue":"8","key":"1538_CR239","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.3913","volume":"21","author":"E Zenaro","year":"2015","unstructured":"Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S et al (2015) Neutrophils promote Alzheimer\u2019s disease\u2013like pathology and cognitive decline via LFA-1 integrin. Nat Med 21(8):880\u2013886","journal-title":"Nat Med"},{"issue":"10","key":"1538_CR240","doi-asserted-by":"publisher","first-page":"e75786","DOI":"10.1371\/journal.pone.0075786","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Ke KF, Liu Z, Qiu YH, Peng YP (2013a) Th17 cell-mediated neuroinflammation is involved in neurodegeneration of a\u03b21-42-induced Alzheimer\u2019s disease model rats. PLoS ONE 8(10):e75786","journal-title":"PLoS ONE"},{"key":"1538_CR241","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/CIA.S40405","volume":"8","author":"YY Zhang","year":"2013","unstructured":"Zhang YY, Fan YC, Wang M, Wang D, Li XH (2013b) Atorvastatin attenuates the production of IL-1\u03b2, IL-6, and TNF-\u03b1 in the hippocampus of an amyloid \u03b21-42-induced rat model of Alzheimer\u2019s disease. Clin Interv Aging 8:103\u2013110. https:\/\/doi.org\/10.2147\/CIA.S40405","journal-title":"Clin Interv Aging"},{"issue":"2","key":"1538_CR242","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jss.2014.07.042","volume":"193","author":"B Zhang","year":"2015","unstructured":"Zhang B, Crankshaw W, Nesemeier R, Patel J, Nweze I, Lakshmanan J et al (2015) Calcium-mediated signaling and calmodulin-dependent kinase regulate hepatocyte-inducible nitric oxide synthase expression. J Surg Res 193(2):795\u2013801","journal-title":"J Surg Res"},{"issue":"3","key":"1538_CR243","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.intimp.2007.12.012","volume":"8","author":"LT Zheng","year":"2008","unstructured":"Zheng LT, Ock J, Kwon BM, Suk K (2008) Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 8(3):484\u2013494. https:\/\/doi.org\/10.1016\/j.intimp.2007.12.012","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1538_CR244","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1471-4159.2009.06263.x","volume":"110","author":"Z Zhou","year":"2009","unstructured":"Zhou Z, Peng X, Insolera R, Fink DJ, Mata M (2009) Interleukin-10 provides direct trophic support to neurons. J Neurochem 110(5):1617\u20131627","journal-title":"J Neurochem"},{"key":"1538_CR245","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jneuroim.2014.06.026","volume":"274","author":"XC Zhu","year":"2014","unstructured":"Zhu XC, Tan L, Jiang T, Tan MS, Zhang W, Yu JT (2014) Association of IL-12A and IL-12B polymorphisms with Alzheimer\u2019s disease susceptibility in a Han Chinese population. J Neuroimmunol 274:180\u2013184","journal-title":"J Neuroimmunol"},{"key":"1538_CR246","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1471-4159.2003.02018.x","volume":"87","author":"K Zou","year":"2003","unstructured":"Zou K, Kim D, Kakio A, Byun K, Gong J, Kim J et al (2003) Amyloid \u03b2-protein (A\u03b2) 1\u201340 protects neurons from damage induced by A\u03b21\u201342 in culture and in rat brain. J Neurochem 87:609\u2013619","journal-title":"J Neurochem"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01538-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01538-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01538-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T04:43:38Z","timestamp":1740804218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01538-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":246,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1538"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01538-5","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}